产品介绍：
产品说明
生化/生理作用
Buparvaquone is a second-generation hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. Buparvaquone is indicated for the therapy and prophylaxis of all forms of Theileriosis and found to have an anti-Leishmanial activity.
基本信息
| 经验(实验)分子式 | C21H26O3 |
| 分子量 | 326.43 |
| MDL编号 | MFCD01712789 |
| PubChem化学物质编号 | 329826000 |
产品性质
| 质量水平 | 200 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 溶解性 | DMSO: soluble chloroform: soluble |
| 储存温度 | 2-8℃ |
| SMILES string | CC(C)(C)C1CCC(CC1)CC2=C(O)C(=O)c3ccccc3C2=O |
| InChI | 1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3 |
| InChI key | KLLIVCPQDTYMLC-UHFFFAOYSA-N |
安全信息
| 危险声明 | H413 |
| 危险分类 | Aquatic Chronic 4 |
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
